The sequel of 1α-hydroxylase overexpression are elevated 1,25(OH)2D3 levels, causing hypercalcemia, hyperphosphatemia, ectopic calcifications, impaired bone mineralization, and early lethality in αKlotho and Fgf23 deficient mice (25–27). This evidence concerns the gene FGF23 and hypercalcemia disease.